img

Global Rivastigmine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rivastigmine Market Insights, Forecast to 2034

Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
Global Rivastigmine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rivastigmine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Rivastigmine key manufacturers include Novartis, Sun Pharmaceutical, Alvogen, Mylan Pharmaceuticals, Teva, Dr. Reddy's Laboratories, Orchid Healthcare, APOTEX and Alembic Pharmaceuticals, etc. Novartis, Sun Pharmaceutical, Alvogen are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Rivastigmine were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Rivastigmine market and estimated to attract more attentions from industry insiders and investors.
Rivastigmine can be divided into Oral and Transdermal Patch, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Rivastigmine is widely used in various fields, such as Alzheimer's Disease and Parkinson's Disease, etc. Alzheimer's Disease provides greatest supports to the Rivastigmine industry development. In 2022, global % sales of Rivastigmine went into Alzheimer's Disease filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Rivastigmine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rivastigmine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Sun Pharmaceutical
Alvogen
Mylan Pharmaceuticals
Teva
Dr. Reddy's Laboratories
Orchid Healthcare
APOTEX
Alembic Pharmaceuticals
MACLEODS
Cadila Pharmaceuticals
Aurobindo Pharma
Ajanta Pharma
Segment by Type
Oral
Transdermal Patch

Segment by Application


Alzheimer's Disease
Parkinson's Disease

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rivastigmine plant distribution, commercial date of Rivastigmine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rivastigmine introduction, etc. Rivastigmine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Rivastigmine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Rivastigmine Product Introduction
1.2 Market by Type
1.2.1 Global Rivastigmine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Transdermal Patch
1.3 Market by Application
1.3.1 Global Rivastigmine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Alzheimer's Disease
1.3.3 Parkinson's Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rivastigmine Sales Estimates and Forecasts 2018-2029
2.2 Global Rivastigmine Revenue by Region
2.2.1 Global Rivastigmine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rivastigmine Revenue by Region (2018-2024)
2.2.3 Global Rivastigmine Revenue by Region (2024-2029)
2.2.4 Global Rivastigmine Revenue Market Share by Region (2018-2029)
2.3 Global Rivastigmine Sales Estimates and Forecasts 2018-2029
2.4 Global Rivastigmine Sales by Region
2.4.1 Global Rivastigmine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rivastigmine Sales by Region (2018-2024)
2.4.3 Global Rivastigmine Sales by Region (2024-2029)
2.4.4 Global Rivastigmine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rivastigmine Sales by Manufacturers
3.1.1 Global Rivastigmine Sales by Manufacturers (2018-2024)
3.1.2 Global Rivastigmine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rivastigmine in 2022
3.2 Global Rivastigmine Revenue by Manufacturers
3.2.1 Global Rivastigmine Revenue by Manufacturers (2018-2024)
3.2.2 Global Rivastigmine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rivastigmine Revenue in 2022
3.3 Global Key Players of Rivastigmine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Rivastigmine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rivastigmine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rivastigmine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rivastigmine, Product Offered and Application
3.8 Global Key Manufacturers of Rivastigmine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rivastigmine Sales by Type
4.1.1 Global Rivastigmine Historical Sales by Type (2018-2024)
4.1.2 Global Rivastigmine Forecasted Sales by Type (2024-2029)
4.1.3 Global Rivastigmine Sales Market Share by Type (2018-2029)
4.2 Global Rivastigmine Revenue by Type
4.2.1 Global Rivastigmine Historical Revenue by Type (2018-2024)
4.2.2 Global Rivastigmine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rivastigmine Revenue Market Share by Type (2018-2029)
4.3 Global Rivastigmine Price by Type
4.3.1 Global Rivastigmine Price by Type (2018-2024)
4.3.2 Global Rivastigmine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rivastigmine Sales by Application
5.1.1 Global Rivastigmine Historical Sales by Application (2018-2024)
5.1.2 Global Rivastigmine Forecasted Sales by Application (2024-2029)
5.1.3 Global Rivastigmine Sales Market Share by Application (2018-2029)
5.2 Global Rivastigmine Revenue by Application
5.2.1 Global Rivastigmine Historical Revenue by Application (2018-2024)
5.2.2 Global Rivastigmine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rivastigmine Revenue Market Share by Application (2018-2029)
5.3 Global Rivastigmine Price by Application
5.3.1 Global Rivastigmine Price by Application (2018-2024)
5.3.2 Global Rivastigmine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rivastigmine Market Size by Type
6.1.1 US & Canada Rivastigmine Sales by Type (2018-2029)
6.1.2 US & Canada Rivastigmine Revenue by Type (2018-2029)
6.2 US & Canada Rivastigmine Market Size by Application
6.2.1 US & Canada Rivastigmine Sales by Application (2018-2029)
6.2.2 US & Canada Rivastigmine Revenue by Application (2018-2029)
6.3 US & Canada Rivastigmine Market Size by Country
6.3.1 US & Canada Rivastigmine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rivastigmine Sales by Country (2018-2029)
6.3.3 US & Canada Rivastigmine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rivastigmine Market Size by Type
7.1.1 Europe Rivastigmine Sales by Type (2018-2029)
7.1.2 Europe Rivastigmine Revenue by Type (2018-2029)
7.2 Europe Rivastigmine Market Size by Application
7.2.1 Europe Rivastigmine Sales by Application (2018-2029)
7.2.2 Europe Rivastigmine Revenue by Application (2018-2029)
7.3 Europe Rivastigmine Market Size by Country
7.3.1 Europe Rivastigmine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rivastigmine Sales by Country (2018-2029)
7.3.3 Europe Rivastigmine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rivastigmine Market Size
8.1.1 China Rivastigmine Sales (2018-2029)
8.1.2 China Rivastigmine Revenue (2018-2029)
8.2 China Rivastigmine Market Size by Application
8.2.1 China Rivastigmine Sales by Application (2018-2029)
8.2.2 China Rivastigmine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rivastigmine Market Size by Type
9.1.1 Asia Rivastigmine Sales by Type (2018-2029)
9.1.2 Asia Rivastigmine Revenue by Type (2018-2029)
9.2 Asia Rivastigmine Market Size by Application
9.2.1 Asia Rivastigmine Sales by Application (2018-2029)
9.2.2 Asia Rivastigmine Revenue by Application (2018-2029)
9.3 Asia Rivastigmine Sales by Region
9.3.1 Asia Rivastigmine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rivastigmine Revenue by Region (2018-2029)
9.3.3 Asia Rivastigmine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rivastigmine Market Size by Type
10.1.1 Middle East, Africa and Latin America Rivastigmine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rivastigmine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rivastigmine Market Size by Application
10.2.1 Middle East, Africa and Latin America Rivastigmine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rivastigmine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rivastigmine Sales by Country
10.3.1 Middle East, Africa and Latin America Rivastigmine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rivastigmine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rivastigmine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Information
11.2.2 Sun Pharmaceutical Overview
11.2.3 Sun Pharmaceutical Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sun Pharmaceutical Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Recent Developments
11.3 Alvogen
11.3.1 Alvogen Company Information
11.3.2 Alvogen Overview
11.3.3 Alvogen Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Alvogen Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Alvogen Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Company Information
11.4.2 Mylan Pharmaceuticals Overview
11.4.3 Mylan Pharmaceuticals Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Pharmaceuticals Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Pharmaceuticals Recent Developments
11.5 Teva
11.5.1 Teva Company Information
11.5.2 Teva Overview
11.5.3 Teva Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Teva Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Recent Developments
11.6 Dr. Reddy's Laboratories
11.6.1 Dr. Reddy's Laboratories Company Information
11.6.2 Dr. Reddy's Laboratories Overview
11.6.3 Dr. Reddy's Laboratories Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Dr. Reddy's Laboratories Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dr. Reddy's Laboratories Recent Developments
11.7 Orchid Healthcare
11.7.1 Orchid Healthcare Company Information
11.7.2 Orchid Healthcare Overview
11.7.3 Orchid Healthcare Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Orchid Healthcare Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Orchid Healthcare Recent Developments
11.8 APOTEX
11.8.1 APOTEX Company Information
11.8.2 APOTEX Overview
11.8.3 APOTEX Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 APOTEX Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 APOTEX Recent Developments
11.9 Alembic Pharmaceuticals
11.9.1 Alembic Pharmaceuticals Company Information
11.9.2 Alembic Pharmaceuticals Overview
11.9.3 Alembic Pharmaceuticals Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Alembic Pharmaceuticals Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Alembic Pharmaceuticals Recent Developments
11.10 MACLEODS
11.10.1 MACLEODS Company Information
11.10.2 MACLEODS Overview
11.10.3 MACLEODS Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 MACLEODS Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 MACLEODS Recent Developments
11.11 Cadila Pharmaceuticals
11.11.1 Cadila Pharmaceuticals Company Information
11.11.2 Cadila Pharmaceuticals Overview
11.11.3 Cadila Pharmaceuticals Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Cadila Pharmaceuticals Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cadila Pharmaceuticals Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Information
11.12.2 Aurobindo Pharma Overview
11.12.3 Aurobindo Pharma Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Aurobindo Pharma Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aurobindo Pharma Recent Developments
11.13 Ajanta Pharma
11.13.1 Ajanta Pharma Company Information
11.13.2 Ajanta Pharma Overview
11.13.3 Ajanta Pharma Rivastigmine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Ajanta Pharma Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ajanta Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rivastigmine Industry Chain Analysis
12.2 Rivastigmine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rivastigmine Production Mode & Process
12.4 Rivastigmine Sales and Marketing
12.4.1 Rivastigmine Sales Channels
12.4.2 Rivastigmine Distributors
12.5 Rivastigmine Customers
13 Market Dynamics
13.1 Rivastigmine Industry Trends
13.2 Rivastigmine Market Drivers
13.3 Rivastigmine Market Challenges
13.4 Rivastigmine Market Restraints
14 Key Findings in The Global Rivastigmine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rivastigmine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Transdermal Patch
Table 4. Global Rivastigmine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Rivastigmine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Rivastigmine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Rivastigmine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Rivastigmine Revenue Market Share by Region (2018-2024)
Table 9. Global Rivastigmine Revenue Market Share by Region (2024-2029)
Table 10. Global Rivastigmine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Rivastigmine Sales by Region (2018-2024) & (K Units)
Table 12. Global Rivastigmine Sales by Region (2024-2029) & (K Units)
Table 13. Global Rivastigmine Sales Market Share by Region (2018-2024)
Table 14. Global Rivastigmine Sales Market Share by Region (2024-2029)
Table 15. Global Rivastigmine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Rivastigmine Sales Share by Manufacturers (2018-2024)
Table 17. Global Rivastigmine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Rivastigmine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Rivastigmine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Rivastigmine Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Rivastigmine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rivastigmine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rivastigmine as of 2022)
Table 23. Global Key Manufacturers of Rivastigmine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rivastigmine, Product Offered and Application
Table 25. Global Key Manufacturers of Rivastigmine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rivastigmine Sales by Type (2018-2024) & (K Units)
Table 28. Global Rivastigmine Sales by Type (2024-2029) & (K Units)
Table 29. Global Rivastigmine Sales Share by Type (2018-2024)
Table 30. Global Rivastigmine Sales Share by Type (2024-2029)
Table 31. Global Rivastigmine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Rivastigmine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Rivastigmine Revenue Share by Type (2018-2024)
Table 34. Global Rivastigmine Revenue Share by Type (2024-2029)
Table 35. Rivastigmine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Rivastigmine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Rivastigmine Sales by Application (2018-2024) & (K Units)
Table 38. Global Rivastigmine Sales by Application (2024-2029) & (K Units)
Table 39. Global Rivastigmine Sales Share by Application (2018-2024)
Table 40. Global Rivastigmine Sales Share by Application (2024-2029)
Table 41. Global Rivastigmine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Rivastigmine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Rivastigmine Revenue Share by Application (2018-2024)
Table 44. Global Rivastigmine Revenue Share by Application (2024-2029)
Table 45. Rivastigmine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Rivastigmine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Rivastigmine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Rivastigmine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Rivastigmine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Rivastigmine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Rivastigmine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Rivastigmine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Rivastigmine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Rivastigmine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Rivastigmine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Rivastigmine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Rivastigmine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Rivastigmine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Rivastigmine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Rivastigmine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Rivastigmine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Rivastigmine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Rivastigmine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Rivastigmine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Rivastigmine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Rivastigmine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Rivastigmine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Rivastigmine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Rivastigmine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Rivastigmine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Rivastigmine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Rivastigmine Sales by Country (2024-2029) & (K Units)
Table 73. China Rivastigmine Sales by Type (2018-2024) & (K Units)
Table 74. China Rivastigmine Sales by Type (2024-2029) & (K Units)
Table 75. China Rivastigmine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Rivastigmine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Rivastigmine Sales by Application (2018-2024) & (K Units)
Table 78. China Rivastigmine Sales by Application (2024-2029) & (K Units)
Table 79. China Rivastigmine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Rivastigmine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Rivastigmine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Rivastigmine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Rivastigmine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Rivastigmine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Rivastigmine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Rivastigmine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Rivastigmine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Rivastigmine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Rivastigmine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Rivastigmine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Rivastigmine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Rivastigmine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Rivastigmine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Rivastigmine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Rivastigmine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Rivastigmine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rivastigmine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rivastigmine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Rivastigmine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Rivastigmine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rivastigmine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rivastigmine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Rivastigmine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rivastigmine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rivastigmine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Rivastigmine Sales by Country (2024-2029) & (K Units)
Table 107. Novartis Company Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Novartis Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novartis Recent Developments
Table 112. Sun Pharmaceutical Company Information
Table 113. Sun Pharmaceutical Description and Major Businesses
Table 114. Sun Pharmaceutical Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Sun Pharmaceutical Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sun Pharmaceutical Recent Developments
Table 117. Alvogen Company Information
Table 118. Alvogen Description and Major Businesses
Table 119. Alvogen Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Alvogen Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Alvogen Recent Developments
Table 122. Mylan Pharmaceuticals Company Information
Table 123. Mylan Pharmaceuticals Description and Major Businesses
Table 124. Mylan Pharmaceuticals Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Mylan Pharmaceuticals Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Pharmaceuticals Recent Developments
Table 127. Teva Company Information
Table 128. Teva Description and Major Businesses
Table 129. Teva Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Teva Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Teva Recent Developments
Table 132. Dr. Reddy's Laboratories Company Information
Table 133. Dr. Reddy's Laboratories Description and Major Businesses
Table 134. Dr. Reddy's Laboratories Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Dr. Reddy's Laboratories Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dr. Reddy's Laboratories Recent Developments
Table 137. Orchid Healthcare Company Information
Table 138. Orchid Healthcare Description and Major Businesses
Table 139. Orchid Healthcare Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Orchid Healthcare Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Orchid Healthcare Recent Developments
Table 142. APOTEX Company Information
Table 143. APOTEX Description and Major Businesses
Table 144. APOTEX Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. APOTEX Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. APOTEX Recent Developments
Table 147. Alembic Pharmaceuticals Company Information
Table 148. Alembic Pharmaceuticals Description and Major Businesses
Table 149. Alembic Pharmaceuticals Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Alembic Pharmaceuticals Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Alembic Pharmaceuticals Recent Developments
Table 152. MACLEODS Company Information
Table 153. MACLEODS Description and Major Businesses
Table 154. MACLEODS Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. MACLEODS Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. MACLEODS Recent Developments
Table 157. Cadila Pharmaceuticals Company Information
Table 158. Cadila Pharmaceuticals Description and Major Businesses
Table 159. Cadila Pharmaceuticals Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Cadila Pharmaceuticals Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Cadila Pharmaceuticals Recent Developments
Table 162. Aurobindo Pharma Company Information
Table 163. Aurobindo Pharma Description and Major Businesses
Table 164. Aurobindo Pharma Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Aurobindo Pharma Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Aurobindo Pharma Recent Developments
Table 167. Ajanta Pharma Company Information
Table 168. Ajanta Pharma Description and Major Businesses
Table 169. Ajanta Pharma Rivastigmine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Ajanta Pharma Rivastigmine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Ajanta Pharma Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Rivastigmine Distributors List
Table 175. Rivastigmine Customers List
Table 176. Rivastigmine Market Trends
Table 177. Rivastigmine Market Drivers
Table 178. Rivastigmine Market Challenges
Table 179. Rivastigmine Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Rivastigmine Product Picture
Figure 2. Global Rivastigmine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rivastigmine Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Transdermal Patch Product Picture
Figure 6. Global Rivastigmine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Rivastigmine Market Share by Application in 2022 & 2029
Figure 8. Alzheimer's Disease
Figure 9. Parkinson's Disease
Figure 10. Rivastigmine Report Years Considered
Figure 11. Global Rivastigmine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Rivastigmine Revenue 2018-2029 (US$ Million)
Figure 13. Global Rivastigmine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Rivastigmine Revenue Market Share by Region (2018-2029)
Figure 15. Global Rivastigmine Sales 2018-2029 ((K Units)
Figure 16. Global Rivastigmine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Rivastigmine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Rivastigmine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Rivastigmine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Rivastigmine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Rivastigmine Sales YoY (2018-2029) & (K Units)
Figure 22. China Rivastigmine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Rivastigmine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Rivastigmine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Rivastigmine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Rivastigmine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Rivastigmine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Rivastigmine in the World: Market Share by Rivastigmine Revenue in 2022
Figure 29. Global Rivastigmine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Rivastigmine Sales Market Share by Type (2018-2029)
Figure 31. Global Rivastigmine Revenue Market Share by Type (2018-2029)
Figure 32. Global Rivastigmine Sales Market Share by Application (2018-2029)
Figure 33. Global Rivastigmine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Rivastigmine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Rivastigmine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Rivastigmine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Rivastigmine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Rivastigmine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Rivastigmine Sales Share by Country (2018-2029)
Figure 40. U.S. Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Rivastigmine Sales Market Share by Type (2018-2029)
Figure 43. Europe Rivastigmine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Rivastigmine Sales Market Share by Application (2018-2029)
Figure 45. Europe Rivastigmine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Rivastigmine Revenue Share by Country (2018-2029)
Figure 47. Europe Rivastigmine Sales Share by Country (2018-2029)
Figure 48. Germany Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 49. France Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 53. China Rivastigmine Sales Market Share by Type (2018-2029)
Figure 54. China Rivastigmine Revenue Market Share by Type (2018-2029)
Figure 55. China Rivastigmine Sales Market Share by Application (2018-2029)
Figure 56. China Rivastigmine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Rivastigmine Sales Market Share by Type (2018-2029)
Figure 58. Asia Rivastigmine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Rivastigmine Sales Market Share by Application (2018-2029)
Figure 60. Asia Rivastigmine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Rivastigmine Revenue Share by Region (2018-2029)
Figure 62. Asia Rivastigmine Sales Share by Region (2018-2029)
Figure 63. Japan Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 67. India Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Rivastigmine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Rivastigmine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Rivastigmine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Rivastigmine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Rivastigmine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Rivastigmine Sales Share by Country (2018-2029)
Figure 74. Brazil Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Rivastigmine Revenue (2018-2029) & (US$ Million)
Figure 79. Rivastigmine Value Chain
Figure 80. Rivastigmine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries